RecallDepth
Class I Terminated

Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.

Company
Avkare
Recall Initiated
March 28, 2024
Posted
April 24, 2024
Recall Number
D-0444-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
153 cartons
Firm Location
Pulaski, TN, United States

Reason for Recall

Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.

Distribution

US Nationwide.

Lot / Code Info

Lot: AW0221A Exp. 08/30/2025

More recalls by Avkare

View all recalls by this company →

Other recent Class I Drug recalls